These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17922546)

  • 1. Synthesis, analysis, in vitro characterization, and in vivo disposition of a lamivudine-dextran conjugate for selective antiviral delivery to the liver.
    Chimalakonda KC; Agarwal HK; Kumar A; Parang K; Mehvar R
    Bioconjug Chem; 2007; 18(6):2097-108. PubMed ID: 17922546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: plasma and tissue disposition.
    Zhang X; Mehvar R
    J Pharm Sci; 2001 Dec; 90(12):2078-87. PubMed ID: 11745766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro characterization of novel dextran-methylprednisolone conjugates with peptide linkers: effects of linker length on hydrolytic and enzymatic release of methylprednisolone and its peptidyl intermediates.
    Penugonda S; Kumar A; Agarwal HK; Parang K; Mehvar R
    J Pharm Sci; 2008 Jul; 97(7):2649-64. PubMed ID: 17853426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on acyclovir-dextran conjugate: synthesis and pharmacokinetics.
    Tu J; Zhong S; Li P
    Drug Dev Ind Pharm; 2004; 30(9):959-65. PubMed ID: 15554220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes.
    Mehvar R; Dann RO; Hoganson DA
    J Control Release; 2000 Jul; 68(1):53-61. PubMed ID: 10884579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.
    Kim W; Yang Y; Kim D; Jeong S; Yoo JW; Yoon JH; Jung Y
    Drug Des Devel Ther; 2017; 11():419-429. PubMed ID: 28243064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of (125) I-lamivudine and (125) I-lamivudine-ursodeoxycholic acid codrug.
    Motaleb MA; Abo-Kul M; Ibrahim SM; Saad SM; Arafat M
    J Labelled Comp Radiopharm; 2016 Sep; 59(11):451-3. PubMed ID: 27561199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal permeability of lamivudine (3TC) and two novel 3TC prodrugs. Experimental and theoretical analyses.
    Gualdesi MS; Briñón MC; Quevedo MA
    Eur J Pharm Sci; 2012 Dec; 47(5):965-78. PubMed ID: 23072916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma pharmacokinetics and tissue disposition of novel dextran-methylprednisolone conjugates with peptide linkers in rats.
    Penugonda S; Agarwal HK; Parang K; Mehvar R
    J Pharm Sci; 2010 Mar; 99(3):1626-37. PubMed ID: 19780131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction.
    Heald AE; Hsyu PH; Yuen GJ; Robinson P; Mydlow P; Bartlett JA
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1514-9. PubMed ID: 8726029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver.
    Erion MD; Reddy KR; Boyer SH; Matelich MC; Gomez-Galeno J; Lemus RH; Ugarkar BG; Colby TJ; Schanzer J; Van Poelje PD
    J Am Chem Soc; 2004 Apr; 126(16):5154-63. PubMed ID: 15099098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats.
    Mehvar R; Hoganson DA
    Pharm Res; 2000 Nov; 17(11):1402-7. PubMed ID: 11205734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5'-phosphonate derivatives of 2',3'-dideoxy-3'-thiacytidine as new anti-HIV prodrugs.
    Khandazhinskaya AL; Jasko MV; Karpenko IL; Solyev PN; Golubeva NA; Kukhanova MK
    Chem Biol Drug Des; 2011 Jul; 78(1):50-6. PubMed ID: 21518262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a dextran-budesonide prodrug for inhalation therapy.
    Waters RC; Hochhaus G
    Eur J Pharm Sci; 2019 Mar; 129():58-67. PubMed ID: 30521945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.
    McLeod AD; Friend DR; Tozer TN
    J Pharm Sci; 1994 Sep; 83(9):1284-8. PubMed ID: 7530303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid and sensitive method for simultaneous determination of lamivudine and zidovudine in human serum by on-line solid-phase extraction coupled to liquid chromatography/tandem mass spectrometry detection.
    Estrela Rde C; Salvadori MC; Suarez-Kurtz G
    Rapid Commun Mass Spectrom; 2004; 18(10):1147-55. PubMed ID: 15150840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting.
    Pang YN; Zhang Y; Zhang ZR
    World J Gastroenterol; 2002 Oct; 8(5):913-7. PubMed ID: 12378641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and pharmacokinetics of the combination Zidovudine plus Lamivudine in the adult Erythrocebus patas monkey determined by liquid chromatography-tandem mass spectrometric analysis.
    Divi RL; Doerge DR; Twaddle NC; Shockley ME; St Claire MC; Harbaugh JW; Harbaugh SW; Poirier MC
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):206-11. PubMed ID: 17949768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent nonclassical nucleoside antiviral drugs based on the N,N-diarylformamidine concept.
    Anastasi C; Hantz O; De Clercq E; Pannecouque C; Clayette P; Dereuddre-Bosquet N; Dormont D; Gondois-Rey F; Hirsch I; Kraus JL
    J Med Chem; 2004 Feb; 47(5):1183-92. PubMed ID: 14971898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of 5'-O-carbonate-2',3'-dideoxy-3'-thiacytidine prodrugs against hepatitis B virus in HepG2 2.2.15 cells.
    Gagey D; Ravetti S; Castro EF; Gualdesi MS; Briñon MC; Campos RH; Cavallaro LV
    Int J Antimicrob Agents; 2010 Dec; 36(6):566-9. PubMed ID: 20947311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.